Stoke Therapeutics, Inc. STOK EV / sales
EV / sales at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s ev / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s EV / sales?
- Stoke Therapeutics, Inc. (STOK) reported EV / sales of 55.3× in Q1 2026.
- How has Stoke Therapeutics, Inc.'s EV / sales changed year-over-year?
- Stoke Therapeutics, Inc.'s EV / sales increased by 11530.3% year-over-year, from 0.5× to 55.3×.
- What is the long-term trend for Stoke Therapeutics, Inc.'s EV / sales?
- Over 3 years (2022 to 2025), Stoke Therapeutics, Inc.'s EV / sales has grown at a -23.0% compound annual growth rate (CAGR), from 20.6× to 9.4×.
- What does EV / sales mean?
- Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.